Early disappearance of maternal anti-measles, mumps, rubella, and varicella antibodies in Indian infants
- 1 March 2019
- Vol. 37 (11) , 1443-1448
Abstract
No abstract availableKeywords
Funding Information
- GlaxoSmithKline Biologicals SA (207269)
This publication has 21 references indexed in Scilit:
- Measles Vaccination in the Presence or Absence of Maternal Measles Antibody: Impact on Child SurvivalClinical Infectious Diseases, 2014
- Lower Transplacental Antibody Transport for Measles, Mumps, Rubella and Varicella Zoster in Very Preterm InfantsPLOS ONE, 2014
- A Randomized Trial of a Standard Dose of Edmonston-Zagreb Measles Vaccine Given at 4.5 Months of Age: Effect on Total Hospital AdmissionsThe Journal of Infectious Diseases, 2014
- Waning of Maternal Antibodies Against Measles, Mumps, Rubella, and Varicella in Communities With Contrasting Vaccination CoverageThe Journal of Infectious Diseases, 2013
- Age-appropriate vaccination against measles and DPT-3 in India – closing the gapsBMC Public Health, 2013
- Evaluation of the establishment of herd immunity in the population by means of serological surveys and vaccination coverageHuman Vaccines & Immunotherapeutics, 2012
- Seroprevalence of measles and natural rubella antibodies among children in Bangui, Central African RepublicBMC Public Health, 2011
- Inverse correlation between varicella severity and level of anti-Varicella Zoster Virus maternal antibodies in infants below one year of ageHuman Vaccines, 2011
- Non-specific effects of standard measles vaccine at 4.5 and 9 months of age on childhood mortality: randomised controlled trialBMJ, 2010
- Prevalence of IgG Antibody Against Measles, Mumps and Rubella in Bangladeshi Children: A Pilot Study to Evaluate the Need for Integrated Vaccination StrategyScandinavian Journal of Immunology, 2006